News Release
Home
News Release
2008
Latest
● 2023
● 2022
● 2021
● 2020
● 2019
● 2018
● 2017
● 2016
● 2015
● 2014
● 2013
● 2012
● 2011
● 2010
● 2009
● 2008
● 2007
● 2006
● 2005
● 2004
● 2003
● 2002
2008.12.25
FY02/2009 Q3 Results Earnings Release Presentation
2008.10.31
Application filed for a transdermal patch containing buprenorphine designed to control moderate to severe, chronic lower back and osteoarthritis pain (Development code: BTDS)
2008.10.09
FY02/2009 Q2 Results Earnings Pelease Presentation
2008.09.25
Notice Regarding Performance Forecasts
2008.07.01
FY02/2009 Q1 Results Earnings Pelease Presentation
2008.06.26
Application filed for a transdermal absorption-type continuous-action drugto treat cancer pain(Development code: HFT-290)
2008.06.18
Conclusion of a joint sales agreement on a transdermal absorption-type continuous-action drug to treat cancer pain(Development code: HFT-290)
2008.04.08
FY02/2008 Q4 Results Earnings Pelease Presentation
2008.03.27
Information on Countermeasures(Takeover Defenses) for Large-scale Purchases of Hisamitsu Stock
2008.02.22
Press Release relating to FDA Approval for SALONPASR PAIN RELEAF PATCH (code: FS-67, topical analgesic product) under NDA
